| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Elard Bottoni-Tito, Wendy Messa-Aguila. Haematological adverse effects associated with olanzapine in adolescents with anorexia nervosa: Three case reports. Revista Colombiana de psiquiatria (English ed.). 2024-04-23. PMID:38653660. |
haematological adverse effects associated with olanzapine in adolescents with anorexia nervosa: three case reports. |
2024-04-23 |
2024-04-26 |
Not clear |
| Elard Bottoni-Tito, Wendy Messa-Aguila. Haematological adverse effects associated with olanzapine in adolescents with anorexia nervosa: Three case reports. Revista Colombiana de psiquiatria (English ed.). 2024-04-23. PMID:38653660. |
to describe haematological adverse effects in adolescents with anorexia nervosa who are taking olanzapine. |
2024-04-23 |
2024-04-26 |
Not clear |
| Jacopo Pruccoli, Elena Barbieri, Caterina Visconti, Beatrice Pranzetti, Ilaria Pettenuzzo, Filomena Moscano, Elisabetta Malaspina, Marastella Marino, Beatrice Valeriani, Antonia Parmeggian. Refeeding syndrome and psychopharmacological interventions in children and adolescents with Anorexia Nervosa: a focus on olanzapine-related modifications of electrolyte balance. European journal of pediatrics. 2024-02-12. PMID:38347260. |
this study aims to investigate the potential correlation between the use of olanzapine, a psychopharmacological intervention commonly prescribed in anorexia nervosa treatment, and the occurrence of refeeding syndrome. |
2024-02-12 |
2024-02-15 |
Not clear |
| Jacopo Pruccoli, Elena Barbieri, Caterina Visconti, Beatrice Pranzetti, Ilaria Pettenuzzo, Filomena Moscano, Elisabetta Malaspina, Marastella Marino, Beatrice Valeriani, Antonia Parmeggian. Refeeding syndrome and psychopharmacological interventions in children and adolescents with Anorexia Nervosa: a focus on olanzapine-related modifications of electrolyte balance. European journal of pediatrics. 2024-02-12. PMID:38347260. |
despite the acknowledged nutritional and biochemical impacts of olanzapine, the literature lacks information regarding its specific association with refeeding syndrome onset in individuals with anorexia nervosa. |
2024-02-12 |
2024-02-15 |
Not clear |
| Jacopo Pruccoli, Elena Barbieri, Caterina Visconti, Beatrice Pranzetti, Ilaria Pettenuzzo, Filomena Moscano, Elisabetta Malaspina, Marastella Marino, Beatrice Valeriani, Antonia Parmeggian. Refeeding syndrome and psychopharmacological interventions in children and adolescents with Anorexia Nervosa: a focus on olanzapine-related modifications of electrolyte balance. European journal of pediatrics. 2024-02-12. PMID:38347260. |
this is a naturalistic, retrospective, observational study, reporting the occurrence of refeeding syndrome in children and adolescents with anorexia nervosa, treated or untreated with olanzapine. |
2024-02-12 |
2024-02-15 |
Not clear |
| Jacopo Pruccoli, Elena Barbieri, Caterina Visconti, Beatrice Pranzetti, Ilaria Pettenuzzo, Filomena Moscano, Elisabetta Malaspina, Marastella Marino, Beatrice Valeriani, Antonia Parmeggian. Refeeding syndrome and psychopharmacological interventions in children and adolescents with Anorexia Nervosa: a focus on olanzapine-related modifications of electrolyte balance. European journal of pediatrics. 2024-02-12. PMID:38347260. |
the mean prescribed doses and serum concentrations of olanzapine were comparable between refeeding syndrome and no-refeeding syndrome patients. conclusion: the present paper describes the occurrence of refeeding syndrome and its association with olanzapine prescriptions in children and adolescents with anorexia nervosa. |
2024-02-12 |
2024-02-15 |
Not clear |
| Jacopo Pruccoli, Elena Barbieri, Caterina Visconti, Beatrice Pranzetti, Ilaria Pettenuzzo, Filomena Moscano, Elisabetta Malaspina, Marastella Marino, Beatrice Valeriani, Antonia Parmeggian. Refeeding syndrome and psychopharmacological interventions in children and adolescents with Anorexia Nervosa: a focus on olanzapine-related modifications of electrolyte balance. European journal of pediatrics. 2024-02-12. PMID:38347260. |
• olanzapine, an atypical antipsychotic with nutritional and biochemical impacts, is used in anorexia nervosa (an) treatment, however data concerning its association with rs are lacking. |
2024-02-12 |
2024-02-15 |
Not clear |
| Olena Said, Ece Sengun Filiz, Dominic Stringer, Briana Applewhite, Vanessa Kellermann, Hiba Mutwalli, Sevgi Bektas, Melahat Nur Akkese, Ashish Kumar, Ben Carter, Mima Simic, Dilveer Sually, Jessica Bentley, Allan H Young, Sloane Madden, Sarah Byford, Sabine Landau, Vanessa Lawrence, Janet Treasure, Ulrike Schmidt, Dasha Nicholls, Hubertus Himmeric. Olanzapine for young PEople with aNorexia nervosa (OPEN): A protocol for an open-label feasibility study. European eating disorders review : the journal of the Eating Disorders Association. 2024-02-01. PMID:38299859. |
olanzapine for young people with anorexia nervosa (open): a protocol for an open-label feasibility study. |
2024-02-01 |
2024-02-03 |
Not clear |
| Andreas Karwautz, Michael Zeiler, Julia Schwarzenberg, Dunja Mairhofer, Michaela Mitterer, Stefanie Truttmann, Julia Philipp, Doris Koubek, Maria Glüder, Gudrun Wagner, Anouk Malcher, Gabriele Schöfbeck, Clarissa Laczkovics, Hans W Rock, Annika Zanko, Hartmut Imgart, Tobias Banaschewski, Christian Fleischhaker, Christoph U Correll, Christoph Wewetzer, Susanne Walitza, Regina Taurines, Stefanie Fekete, Marcel Romanos, Karin Egberts, Manfred Gerlac. Therapeutic drug monitoring in adolescents with anorexia nervosa for safe treatment with adjunct olanzapine. European eating disorders review : the journal of the Eating Disorders Association. 2023-08-18. PMID:37592386. |
therapeutic drug monitoring in adolescents with anorexia nervosa for safe treatment with adjunct olanzapine. |
2023-08-18 |
2023-09-07 |
Not clear |
| Karlijn L Kooij, Mieneke C M Luijendijk, Lisa Drost, Gerard Platenburg, Annemarie van Elburg, Roger A H Ada. Intranasal administration of olanzapine has beneficial outcome in a rat activity-based anorexia model. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 71. 2023-04-09. PMID:37031523. |
the atypical antipsychotic drug olanzapine is prescribed despite clinical studies on olanzapine treatment showing mixed results on treatment efficacy in anorexia nervosa. |
2023-04-09 |
2023-08-14 |
rat |
| Jacopo Pruccoli, Ilaria Pettenuzzo, Antonia Parmeggian. Low-Dose Olanzapine in the Treatment of Adolescents with Anorexia Nervosa: An Observational Naturalistic Case-Control Study. Journal of child and adolescent psychopharmacology. 2022-05-25. PMID:35612433. |
low-dose olanzapine in the treatment of adolescents with anorexia nervosa: an observational naturalistic case-control study. |
2022-05-25 |
2023-08-13 |
Not clear |
| Ruijun Han, Qingtao Bian, Hao Che. Effectiveness of olanzapine in the treatment of anorexia nervosa: A systematic review and meta-analysis. Brain and behavior. 2022-01-12. PMID:35020271. |
effectiveness of olanzapine in the treatment of anorexia nervosa: a systematic review and meta-analysis. |
2022-01-12 |
2023-08-13 |
Not clear |
| Hubertus Himmerich, Carol Kan, Katie Au, Janet Treasur. Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences. Pharmacology & therapeutics. vol 217. 2021-11-15. PMID:32858054. |
thus, there are no approved pharmacological options for anorexia nervosa (an), even though study results for olanzapine and dronabinol are promising. |
2021-11-15 |
2023-08-13 |
Not clear |
| Maris Taub. Hyponatremia caused by water intoxication: successful treatment of psychiatric disturbances with olanzapine and fluoxetine. Oxford medical case reports. vol 2021. issue 1. 2021-02-06. PMID:33542829. |
the present clinical case details the beneficial effects of olanzapine and fluoxetine in treating a patient with anorexia nervosa and body dysmorphic disorder experiencing acute hyponatremia, and the stable effect the medications achieved over a period of 2.5 years of maintenance therapy. |
2021-02-06 |
2023-08-13 |
Not clear |
| Wendy Spettigue, Mark L Norris, Danijela Maras, Nicole Obeid, Stephen Feder, Megan E Harrison, Rebecca Gomez, Maeghan Cy Fu, Katherine Henderson, Annick Buchhol. Evaluation of the Effectiveness and Safety of Olanzapine as an Adjunctive Treatment for Anorexia Nervosa in Adolescents: An Open-Label Trial. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent. vol 27. issue 3. 2020-10-01. PMID:30038658. |
evaluation of the effectiveness and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescents: an open-label trial. |
2020-10-01 |
2023-08-13 |
Not clear |
| Wendy Spettigue, Mark L Norris, Danijela Maras, Nicole Obeid, Stephen Feder, Megan E Harrison, Rebecca Gomez, Maeghan Cy Fu, Katherine Henderson, Annick Buchhol. Evaluation of the Effectiveness and Safety of Olanzapine as an Adjunctive Treatment for Anorexia Nervosa in Adolescents: An Open-Label Trial. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent. vol 27. issue 3. 2020-10-01. PMID:30038658. |
to evaluate the effectiveness and safety of adjunctive olanzapine treatment for low weight adolescents with anorexia nervosa (an). |
2020-10-01 |
2023-08-13 |
Not clear |
| Scott J Cro. Pharmacologic Treatment of Eating Disorders. The Psychiatric clinics of North America. vol 42. issue 2. 2020-02-03. PMID:31046927. |
anorexia nervosa does not generally respond to medications, although recent evidence supports modest weight restoration benefits from olanzapine. |
2020-02-03 |
2023-08-13 |
Not clear |
| Evelyn Attia, Joanna E Steinglass, B Timothy Walsh, Yuanjia Wang, Peng Wu, Colleen Schreyer, Jennifer Wildes, Zeynep Yilmaz, Angela S Guarda, Allan S Kaplan, Marsha D Marcu. Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial. The American journal of psychiatry. vol 176. issue 6. 2019-12-30. PMID:30654643. |
olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. |
2019-12-30 |
2023-08-13 |
Not clear |
| Evelyn Attia, Joanna E Steinglass, B Timothy Walsh, Yuanjia Wang, Peng Wu, Colleen Schreyer, Jennifer Wildes, Zeynep Yilmaz, Angela S Guarda, Allan S Kaplan, Marsha D Marcu. Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial. The American journal of psychiatry. vol 176. issue 6. 2019-12-30. PMID:30654643. |
this study evaluated the benefits of olanzapine compared with placebo for adult outpatients with anorexia nervosa. |
2019-12-30 |
2023-08-13 |
Not clear |
| Lauren E Davis, Evelyn Atti. Recent advances in therapies for eating disorders. F1000Research. vol 8. 2019-10-28. PMID:31598212. |
recent years have seen promising developments in these treatments, including additional support for family-based approaches for children and adolescents, new evidence for "third-wave" behavioral therapies, and new support for the use of lisdexamfetamine for binge eating disorder and olanzapine for anorexia nervosa. |
2019-10-28 |
2023-08-13 |
Not clear |